You have 9 free searches left this month | for more free features.

Nonresponder

Showing 1 - 25 of 84

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthcare Worker, Hepatitis B Vaccine, Nonresponder Trial in Madison (Recombinant hepatitis B vaccine with CpG adjuvant)

Recruiting
  • Healthcare Worker, Hepatitis B Vaccine, Nonresponder
  • Recombinant hepatitis B vaccine with CpG adjuvant
  • Madison, Wisconsin
    University of Wisconsin
Jul 5, 2022

Hypertension, Diabetes Trial in Worldwide (aliskiren)

Completed
  • Hypertension
  • Diabetes
  • Salisbury, North Carolina
  • +6 more
Feb 8, 2020

Measured by Tissue Doppler to Evaluate Fluid Responsiveness

Not yet recruiting
  • Shock
  • Cardiac ultrasonography
  • Nîmes, France
    CHU de Nîmes
Jun 2, 2023

Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)

Recruiting
  • Human Immunodeficiency Virus
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 29, 2022

Gut Microbiota and Cancer Immunotherapy Response

Recruiting
  • Non-Small Cell Lung Cancer
  • Response to anti-PD-1/PD-L1
  • Non-response to anti-PD-1/PD-L1
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Aug 12, 2021

Heart Failure Trial in Shatin (Electrical Activation Mapping Guided Cardiac resynchronization therapy)

Recruiting
  • Heart Failure
  • Electrical Activation Mapping Guided Cardiac resynchronization therapy
  • Shatin, Hong Kong
    The Chinese University of Hong Kong
Sep 22, 2022

Enterobacteriaceae Infections, Multi-antibiotic Resistance Trial in Roma (Donor - FMT, Placebo FMT)

Not yet recruiting
  • Enterobacteriaceae Infections
  • Multi-antibiotic Resistance
  • Donor - FMT
  • Placebo FMT
  • Roma, Italy
    Giovanni Cammarota
Mar 28, 2023

Cardiac Resynchronization Therapy, Heart Failure Trial in Macquarie Park (Cardiac resynchronization therapy by CRT-P or CRT-D

Completed
  • Cardiac Resynchronization Therapy
  • Heart Failure
  • Cardiac resynchronization therapy by CRT-P or CRT-D implantation
  • Macquarie Park, New South Wales, Australia
    Abbott Medical Australia Pty Ltd
Oct 17, 2022

Heart Failure Trial in Shatin (Electrical Activation Mapping Guided Cardiac resynchronization therapy)

Recruiting
  • Heart Failure
  • Electrical Activation Mapping Guided Cardiac resynchronization therapy
  • Shatin, Hong Kong
    The Chinese University of Hong Kong
Sep 22, 2022

Candidiasis, Oral, HIV Trial in Puerto Rico, Tanzania, United States (Amphotericin B)

Completed
  • Candidiasis, Oral
  • HIV Infections
  • Amphotericin B
  • Birmingham, Alabama
  • +31 more
Oct 28, 2021

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Convulsions Trial in Cairo (administration of Nasal midazolam in home group as a rescue medication for seizure control.,

Completed
  • Convulsions
  • administration of Nasal midazolam in home group as a rescue medication for seizure control.
  • +5 more
  • Cairo, Egypt
    Ain Shams Pediatric hospital
Dec 30, 2022

ULCERATIVE COLITIS Trial in France (VEDOLIZUMAB, ADALIMUMAB)

Terminated
  • ULCERATIVE COLITIS
  • Angers, France
  • +3 more
Feb 2, 2021

Western Equine Encephalitis Trial in Fort Deterick (Western Equine Encephalitis (WEE) Vaccine)

Recruiting
  • Western Equine Encephalitis
  • Western Equine Encephalitis (WEE) Vaccine
  • Fort Deterick, Maryland
    Special Immunizations Program, USAMRIID
Feb 10, 2021

Heart Failure, Left Bundle-Branch Block, Ischemic Cardiomyopathy Trial in Tomsk (Cardiac Resynchronization Therapy Devices with

Not yet recruiting
  • Heart Failure
  • +5 more
  • Cardiac Resynchronization Therapy Devices with Defibrillator Function (CRT-D) or CRT-D Leads Replacement
  • +2 more
  • Tomsk, Russian Federation
    Cardiology Research Institute, Tomsk National Research Medical C
Mar 10, 2023

Hemodynamic, Monitoring, Anesthesia, Blood Pressure Trial in Lille (CLEARSIGHT and NICCOMO measurements in sequence A,

Completed
  • Hemodynamic, Monitoring
  • +2 more
  • CLEARSIGHT and NICCOMO measurements in sequence A
  • CLEARSIGHT and NICCOMO measurements in sequence B
  • Lille, France
    Hôpital Roger Salengro, CHU Lille
Apr 20, 2021

Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

Completed
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Heart Failure Trial in Shatin (Electrical Activation Mapping Guided Cardiac resynchronization therapy)

Recruiting
  • Heart Failure
  • Electrical Activation Mapping Guided Cardiac resynchronization therapy
  • Shatin, Hong Kong
    The Chinese University of Hong Kong
Sep 22, 2022

Psoriasis Trial in Japan (risankizumab)

Completed
  • Psoriasis
  • Nagoya-shi, Aichi, Japan
  • +8 more
Nov 16, 2021

Articular Cartilage Defect Trial in Worldwide (autologous cultured chondrocytes on porcine collagen membrane, Microfracture)

Completed
  • Articular Cartilage Defect
  • autologous cultured chondrocytes on porcine collagen membrane
  • Microfracture
  • Brno, Czechia
  • +19 more
May 10, 2021

Specific Phobia Trial in Hartford (D-cycloserine, Exposure therapy, Placebo)

Completed
  • Specific Phobia
  • Hartford, Connecticut
    Institute of Living/Hartford Hospital
Apr 19, 2020

Chronic Hepatitis C Trial (Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body

Completed
  • Chronic Hepatitis C
  • Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks
  • (no location specified)
Nov 21, 2019

Long-term Follow-up of HALT-C Sustained Virological Responders

Completed
  • Hepatitis C
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Pelvic Floor Signs and Symptoms in Women and Men

    Enrolling by invitation
    • Pelvic Floor Disorders
    • questionnaire
    • Groningen, Netherlands
      University Medical Center Groningen
    Nov 3, 2020

    Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

    Completed
    • Chronic Hepatitis C
    • Be'er Sheva, HaDarom, Israel
    • +17 more
    Sep 18, 2019